Free Trial
OTCMKTS:STDAF

STADA Arzneimittel Aktiengesellschaft (STDAF) Stock Price, News & Analysis

STADA Arzneimittel Aktiengesellschaft logo
$110.42 0.00 (0.00%)
As of 10/24/2022

About STADA Arzneimittel Aktiengesellschaft Stock (OTCMKTS:STDAF)

Key Stats

Today's Range
$110.42
$110.42
50-Day Range
$110.42
$110.42
52-Week Range
$75.15
$115.00
Volume
N/A
Average Volume
180 shs
Market Capitalization
$6.88 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive STDAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STADA Arzneimittel Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

STDAF Stock News Headlines

STAFF NEWS
KPLUY K+S Aktiengesellschaft
Cover all your expenses with just $118,000 invested?
Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just discovered a new way to do it with 10X less money.tc pixel
KPLUY K+S Aktiengesellschaft
STADA Arzneimittel AG V (SAZA)
See More Headlines

STDAF Stock Analysis - Frequently Asked Questions

STADA Arzneimittel Aktiengesellschaft's stock was trading at $110.42 at the beginning of the year. Since then, STDAF shares have increased by 0.0% and is now trading at $110.42.

Shares of STDAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/20/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medicinals & Botanicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:STDAF
Previous Symbol
NASDAQ:STDAF
CIK
N/A
Employees
12,500
Year Founded
1895

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
2.23
Current Ratio
1.54
Quick Ratio
0.99

Sales & Book Value

Annual Sales
$3.84 billion
Price / Sales
1.79
Cash Flow
$11.12 per share
Price / Cash Flow
9.93
Book Value
$23.11 per share
Price / Book
4.78

Miscellaneous

Outstanding Shares
62,342,000
Free Float
N/A
Market Cap
$6.88 billion
Optionable
Not Optionable
Beta
0.38

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (OTCMKTS:STDAF) was last updated on 8/20/2025 by MarketBeat.com Staff
From Our Partners